Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 38 Lung Neoplasms 29 Carcinoma, Non-Small-Cell Lung 28 Neoplasms 16 Uterine Cervical Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 11 Esophageal Neoplasms 10 Carcinoma, Hepatocellular 10 Sarcoma 9 Rectal Neoplasms 9 Carcinoma, Renal Cell 9 Prostatic Neoplasms 8 Neoplasm Metastasis 8 Melanoma 8 Lymphoma 8 Glioblastoma 8 Colorectal Neoplasms 8 Brain Neoplasms 8 Thyroid Neoplasms 7 Stomach Neoplasms 7 Solid Tumor 7 Pancreatic Neoplasms 7 Oropharyngeal Neoplasms 7 Multiple Myeloma 7 Head and Neck Neoplasms 7 Colonic Neoplasms 7 Urinary Bladder Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 6 Hodgkin Disease 6 Breast Neoplasms, Male 6

Interventions

Fluorodeoxyglucose F18 1 Cytoreduction Surgical Procedures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cytoreductive Surgery × Fluorodeoxyglucose F18 × Clear all

NCT05390021 2024-04-02

PET/MRI in Endometrial Cancer

Massachusetts General Hospital

Phase NA Withdrawn

Cytoreductive Surgery

Data powered by HemOnc (CC BY 4.0) Colophon ⚡